<DOC>
	<DOCNO>NCT00002508</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Peripheral stem cell transplantation may allow doctor give high dos chemotherapy kill tumor cell . PURPOSE : Phase I/II trial study effectiveness combination chemotherapy follow peripheral stem cell transplantation bone marrow transplantation treat patient relapsed recurrent germ cell cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Followed Bone Marrow Stem Cell Transplantation Treating Patients With Relapsed Refractory Germ Cell Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Determine response rate , overall survival , disease-free survival patient refractory relapse germ cell carcinoma treat high-dose induction chemotherapy comprise carboplatin etoposide follow autologous bone marrow peripheral blood stem cell rescue . OUTLINE : Autologous peripheral blood stem cell ( PBSC ) bone marrow harvest . Patients receive carboplatin IV continuously etoposide IV 1 hour day -5 -3 . Autologous PBSC bone marrow reinfused day 0 . PROJECTED ACCRUAL : A maximum 30 patient accrue study .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Documented relapsed refractory germ cell cancer follow site origin : Testes Ovary Retroperitoneum Mediastinum Other sit Any stage disease allow Any histologic subtype allow Seminoma allow ineligible radiotherapy Failed achieve complete remission ( CR ) follow least 3 course standard platinumcontaining regimen experience clear relapse follow CR obtain regimen Absence tumor marker presence stable residual mass initial treatment may allow ( surgical biopsy perform ; medically safe , confirm persistence disease rule mature teratoma fibrosis ) Prior CNS involvement allow absence gross residual CNS tumor follow definitive local therapy ( surgery plus radiotherapy ) No gross tumor involvement bone marrow biopsy PATIENT CHARACTERISTICS : Age : 15 60 Performance status : Karnofsky 80100 % Hematopoietic : Granulocyte count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin le 2.0 mg/dL SGOT/SGPT le 2 time normal Albumin great 3.0 mg/dL Renal : Creatinine le 1.8 mg/dL Cardiovascular : LVEF least 50 % No serious cardiac disease would preclude transplantation Pulmonary : DLCO , FEV1 , FVC least 50 % predict pO2 least 70 mm Hg room air Other : HIV negative No concurrent serious psychiatric , neurologic , neoplastic , immunologic , medical problem would preclude transplantation Not pregnant PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics No prior chest irradiation Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>recurrent malignant testicular germ cell tumor</keyword>
	<keyword>recurrent ovarian germ cell tumor</keyword>
	<keyword>extragonadal germ cell tumor</keyword>
</DOC>